109 related articles for article (PubMed ID: 24265186)
1. Can high dose methotrexate be continued after severe hypersensitivity reaction?
Marzollo A; Bisogno G
Pediatr Blood Cancer; 2014 Jun; 61(6):1139. PubMed ID: 24265186
[No Abstract] [Full Text] [Related]
2. Hypersensitivity reaction to high-dose methotrexate and successful rechallenge in a pediatric patient with osteosarcoma.
Scott JR; Ward DA; Crews KR; Panetta JC; Navid F
Pediatr Blood Cancer; 2014 Feb; 61(2):373-5. PubMed ID: 23955991
[TBL] [Abstract][Full Text] [Related]
3. Management and successful desensitization in methotrexate-induced anaphylaxis.
Bouchireb K; Dodille A; Ponvert C; Gouraud F; Dubrel M; Brugières L
Pediatr Blood Cancer; 2009 Feb; 52(2):295-7. PubMed ID: 18855892
[TBL] [Abstract][Full Text] [Related]
4. Anaphylaxis during the first course of high-dose methotrexate: a case report and literature review.
Pugi A; Benemei S; Vietri M; Tondo A; Calvani AM; Mugelli A; Vannacci A; Lapi F
J Clin Pharm Ther; 2012 Apr; 37(2):245-8. PubMed ID: 21569069
[TBL] [Abstract][Full Text] [Related]
5. Delayed renal excretion of methotrexate after a severe anaphylactic reaction to methotrexate in a child with osteosarcoma.
Ozguven AA; Uysal K; Gunes D; Koroglu T; Gurcu O; Olgun N
J Pediatr Hematol Oncol; 2009 Apr; 31(4):289-91. PubMed ID: 19346884
[TBL] [Abstract][Full Text] [Related]
6. Anaphylactoid reaction to high-dose methotrexate and successful desensitization.
Oulego-Erroz I; Maneiro-Freire M; Bouzón-Alejandro M; Vázquez-Donsión M; Couselo JM
Pediatr Blood Cancer; 2010 Sep; 55(3):557-9. PubMed ID: 20533520
[TBL] [Abstract][Full Text] [Related]
7. High-dose methotrexate in fibroblastic osteosarcoma.
Chowbay B; Siong KK
Ann Pharmacother; 2001 Dec; 35(12):1669. PubMed ID: 11793640
[No Abstract] [Full Text] [Related]
8. Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma: analysis of the literature.
Bielack SS; Beron G; Winkler K
Cancer; 1997 Aug; 80(3):516-8. PubMed ID: 9241087
[No Abstract] [Full Text] [Related]
9. Successful desensitization to high-dose methotrexate after systemic anaphylaxis.
Davis KA; Williams P; Walker JC
Ann Allergy Asthma Immunol; 2003 Jan; 90(1):87-9. PubMed ID: 12546343
[TBL] [Abstract][Full Text] [Related]
10. Anaphylactoid reaction to high-dose methotrexate and re-administration after a successful desensitization.
Caldeira T; Costa V; Silva I; Oliva T; Norton L
Pediatr Hematol Oncol; 2008 Mar; 25(2):131-4. PubMed ID: 18363180
[TBL] [Abstract][Full Text] [Related]
11. For Patients With Cancer, Cure Is Not Enough.
Effinger KE; Link MP
JAMA Oncol; 2016 Feb; 2(2):176-8. PubMed ID: 26584335
[No Abstract] [Full Text] [Related]
12. The classic: recent advances in chemotherapy of metastatic osteogenic sarcoma. 1972.
Jaffe N
Clin Orthop Relat Res; 2005 Sep; 438():19-21. PubMed ID: 16131864
[No Abstract] [Full Text] [Related]
13. Neurocognitive outcomes of children with osteosarcoma treated with methotrexate.
Shima H; Sato S; Takimoto T; Sakai M; Hashida N; Isshiki K; Shimada H
Pediatr Int; 2023 Jan; 65(1):e15487. PubMed ID: 36799122
[No Abstract] [Full Text] [Related]
14. Targeted delivery of antineoplastic agent to bone: biodistribution studies of technetium-99m-labeled gem-bisphosphonate conjugate of methotrexate.
Hosain F; Spencer RP; Couthon HM; Sturtz GL
J Nucl Med; 1996 Jan; 37(1):105-7. PubMed ID: 8543977
[TBL] [Abstract][Full Text] [Related]
15. Low-dose methotrexate inhibits lung metastasis and lengthens survival in rat osteosarcoma.
Tomoda R; Seto M; Hioki Y; Sonoda J; Matsumine A; Kusuzaki K; Uchida A
Clin Exp Metastasis; 2005; 22(7):559-64. PubMed ID: 16475026
[TBL] [Abstract][Full Text] [Related]
16. High-dose methotrexate is effective in osteosarcoma so what is the problem?
Cohen IJ
J Pediatr Hematol Oncol; 2009 Dec; 31(12):892-4. PubMed ID: 19887958
[No Abstract] [Full Text] [Related]
17. [Progress and stagnation in chemotherapy protocols for primary osteosarcoma].
Delépine N; Alkallaf S; Cornille H; Markowska B; Delépine G
Ann Med Interne (Paris); 2003 Feb; 154(1):12-24. PubMed ID: 12746655
[TBL] [Abstract][Full Text] [Related]
18. A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcoma.
Johansson ÅM; Hill N; Perisoglou M; Whelan J; Karlsson MO; Standing JF
Ther Drug Monit; 2011 Dec; 33(6):711-8. PubMed ID: 22105588
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy with high-dose methotrexate in osteosarcoma.
Mir O; Ropert S; Goldwasser F
Lancet Oncol; 2008 Dec; 9(12):1198. PubMed ID: 19038767
[No Abstract] [Full Text] [Related]
20. [Methotrexate-leucovorin rescue therapy: pharmacological characteristics and clinical effective use].
Fujimoto T
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1901-6. PubMed ID: 8978794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
